Literature DB >> 21385852

A novel calcium-binding site of von Willebrand factor A2 domain regulates its cleavage by ADAMTS13.

Minyun Zhou1, Xianchi Dong, Carsten Baldauf, Hua Chen, Yanfeng Zhou, Timothy A Springer, Xinping Luo, Chen Zhong, Frauke Gräter, Jianping Ding.   

Abstract

The proteolysis of VWF by ADAMTS13 is an essential step in the regulation of its hemostatic and thrombogenic potential. The cleavage occurs at strand β4 in the structural core of the A2 domain of VWF, so unfolding of the A2 domain is a prerequisite for cleavage. In the present study, we present the crystal structure of an engineered A2 domain that exhibits a significant difference in the α3-β4 loop compared with the previously reported structure of wild-type A2. Intriguingly, a metal ion was detected at a site formed mainly by the C-terminal region of the α3-β4 loop that was later identified as Ca(²+) after various biophysical and biochemical studies. Force-probe molecular dynamic simulations of a modeled structure of the wild-type A2 featuring the discovered Ca(²+)-binding site revealed that an increase in force was needed to unfold strand β4 when Ca(²+) was bound. Cleavage assays consistently demonstrated that Ca(²+) binding stabilized the A2 domain and impeded its unfolding, and consequently protected it from cleavage by ADAMTS13. We have revealed a novel Ca(²+)-binding site at the A2 domain of VWF and demonstrated a relationship between Ca(²+) and force in the regulation of VWF and primary hemostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21385852     DOI: 10.1182/blood-2010-11-321596

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  von Willebrand factor self-association is regulated by the shear-dependent unfolding of the A2 domain.

Authors:  Changjie Zhang; Anju Kelkar; Sriram Neelamegham
Journal:  Blood Adv       Date:  2019-04-09

2.  Mechanisms by which von Willebrand disease mutations destabilize the A2 domain.

Authors:  Amy J Xu; Timothy A Springer
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

3.  A pivotal role for a conserved bulky residue at the α1-helix of the αI integrin domain in ligand binding.

Authors:  Zhengli Wang; Aye Myat Myat Thinn; Jieqing Zhu
Journal:  J Biol Chem       Date:  2017-10-27       Impact factor: 5.157

4.  Role of calcium in regulating the intra- and extracellular cleavage of von Willebrand factor by the protease ADAMTS13.

Authors:  Shobhit Gogia; Anju Kelkar; Changjie Zhang; Kannayakanahalli M Dayananda; Sriram Neelamegham
Journal:  Blood Adv       Date:  2017-10-20

Review 5.  von Willebrand factor, Jedi knight of the bloodstream.

Authors:  Timothy A Springer
Journal:  Blood       Date:  2014-06-13       Impact factor: 22.113

6.  Force interacts with macromolecular structure in activation of TGF-β.

Authors:  Xianchi Dong; Bo Zhao; Roxana E Iacob; Jianghai Zhu; Adem C Koksal; Chafen Lu; John R Engen; Timothy A Springer
Journal:  Nature       Date:  2017-01-25       Impact factor: 49.962

Review 7.  Biology and physics of von Willebrand factor concatamers.

Authors:  T A Springer
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

8.  Conformational activation of ADAMTS13.

Authors:  Kieron South; Brenda M Luken; James T B Crawley; Rebecca Phillips; Mari Thomas; Richard F Collins; Louis Deforche; Karen Vanhoorelbeke; David A Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

9.  N-linked glycan stabilization of the VWF A2 domain.

Authors:  Christopher J Lynch; David A Lane
Journal:  Blood       Date:  2016-01-14       Impact factor: 22.113

10.  Identification of extant vertebrate Myxine glutinosa VWF: evolutionary conservation of primary hemostasis.

Authors:  Marianne A Grant; David L Beeler; Katherine C Spokes; Junmei Chen; Harita Dharaneeswaran; Tracey E Sciuto; Ann M Dvorak; Gianluca Interlandi; José A Lopez; William C Aird
Journal:  Blood       Date:  2017-09-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.